Macular Disease Foundation Australia logo

    Research news

    Research News

    The latest funding round now brings MDFA’s commitment to macular disease research to $5.8 million across 35 projects since 2011.

    Read more

    Most recent

    2025 Grant Family Fund Award Recipient

    Next-generation gene therapy for Stargardt Disease: Enhanced AAV-mediated ABCA4 delivery to restore vision 

    2025 Grant Family Fund Award Recipient

    Macular vascular disease: software standardisation and data harmonisation to accelerate the development of new imaging biomarkers and therapies 

    2025 Research Grant Recipient 

    Genotype-phenotype correlations in PRPH2-associated retinal dystrophy

    2025 Research Grant Recipient  

    Nocturnal hypoxia: An unrecognised risk factor for neovascular age-related macular degeneration

    2025 Research Grant Recipient

    Towards a personalised approach to predicting and preventing progression of age-related macular degeneration 

    2025 Grant Family Fund Award Recipient

    Exploring exosomal therapeutics delivery strategies for macular disease  

    2025 Research Grant Recipient

    Reducing the risk of end-stage complications of neovascular age-related macular degeneration: macular atrophy and subretinal fibrosis

    2025 Research Grant Recipient  

    Driving into the future: strategies to enhance independence for drivers with macular degeneration, including licensing options and the role of modern vehicle technology

    $1 million investment in new macular disease research 

    Macular Disease Foundation Australia (MDFA) has awarded more than $1 million to eight groundbreaking research

    Loading...